ANTHEM

Anthem Biosciences Share Price

 

 

Invest in Anthem Biosciences with 3.38X leverage

Invest with MTF

Performance

  • Low
  • ₹684
  • High
  • ₹700
  • 52 Week Low
  • ₹579
  • 52 Week High
  • ₹874
  • Open Price₹685
  • Previous Close₹686
  • Volume172,154
  • 50 DMA₹654.81
  • 100 DMA₹685.56
  • 200 DMA-

Investment Returns

  • Over 1 Month + 12.89%
  • Over 3 Month + 5.59%
  • Over 6 Month -13.02%
  • Over 1 Year + 22.18%

Smart Investing Starts Here Start SIP with Anthem Biosciences for Steady Growth!

Invest Now

Anthem Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 80.7
  • PEG Ratio
  • -
  • Market Cap Cr
  • 39,118
  • P/B Ratio
  • 14.2
  • Average True Range
  • 20.57
  • EPS
  • 8.95
  • Dividend Yield
  • 0
  • MACD Signal
  • 11.24
  • RSI
  • 65.95
  • MFI
  • 83.6

Anthem Biosciences Financials

Anthem Biosciences Technicals

EMA & SMA

Current Price
₹696.40
+ 9.95 (1.45%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 13
  • 20 Day
  • ₹660.68
  • 50 Day
  • ₹654.81
  • 100 Day
  • ₹685.56
  • 200 Day
  • -

Resistance and Support

693.62 Pivot Speed
  • R3 718.48
  • R2 709.27
  • R1 702.83
  • S1 687.18
  • S2 677.97
  • S3 671.53

Anthem Biosciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-05 Quarterly Results
2025-11-08 Quarterly Results
2025-08-13 Quarterly Results

Anthem Biosciences F&O

Anthem Biosciences Shareholding Pattern

74.69%
6.89%
0.44%
1.37%
0%
9.6%
7.01%

Anthem Biosciences FAQs

Anthem Biosciences share price is ₹696 As on 20 February, 2026 | 02:42

The Market Cap of Anthem Biosciences is ₹39117.8 Cr As on 20 February, 2026 | 02:42

The P/E ratio of Anthem Biosciences is 80.7 As on 20 February, 2026 | 02:42

The PB ratio of Anthem Biosciences is 14.2 As on 20 February, 2026 | 02:42

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23